Search Count: 11
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: NAD, A1AG4
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: NAD, A1AG5
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG6 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-11-27
Ligands: NAD, A1AG6
 |
Structure Of Sars-Cov-2 Main Protease In Complex With A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2024-05-15 Classification: VIRAL PROTEIN Ligands: YDL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-05-15
Ligands: YDL
 |
Structure Of Sars-Cov-2 Main Protease In Complex With A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4W8 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-11-10
Ligands: 4W8
 |
Structure Of Sars-Cov-2 Main Protease In Complex With A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-11-10
Ligands: 4WI
 |
Structure Of Sars-Cov-2 Main Protease In Complex With A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4YG |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-11-10
Ligands: 4YG
 |
Structure Of Sars-Cov-2 Main Protease In Complex With A Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2021-11-10
Ligands: 4WI
 |
Map4K4 In Complex With An Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2016-01-13 Classification: TRANSFERASE/INHIBITOR Ligands: 5DF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-01-13
Ligands: 5DF
 |
Crystal Structure Of Porcine Fructose-1,6-Bisphosphatase Complexed With A Novel Allosteric-Site Inhibitor
Organism: Sus scrofa
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2002-10-16 Classification: HYDROLASE Ligands: F6P, MN, AMP, PFE |
Organism: Sus scrofa
Method: X-RAY DIFFRACTION
Release Date: 2002-10-16
Ligands: F6P, MN, AMP, PFE
 |
Porcine Kidney Fructose-1,6-Bisphosphatase Complexed With An Amp-Site Inhibitor
Organism: Sus scrofa
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2002-10-16 Classification: HYDROLASE Ligands: F6P, MN, CLI |
Organism: Sus scrofa
Method: X-RAY DIFFRACTION
Release Date: 2002-10-16
Ligands: F6P, MN, CLI